HomeProductsBuilding BlocksHeterocyclic ScaffoldsAromatic HeterocyclesInavolisib
Chemical structure of CAS 2060571-02-8

Inavolisib

CAS No.2060571-02-8
MDL No.MFCD31382124
MFC18H19F2N5O4
MW407.40
InChI KeySGEUNORSOZVTOL-CABZTGNLSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.2060571-02-8
Product NameInavolisib

Biological Targets

PIK3CA

Associated Conditions

breast cancer·endometrial cancer·neoplasm·cancer
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Preclinical assessment of the PI3Kα selective inhibitor inavolisib and prediction of its pharmacokinetics and efficacious dose in human.

Xenobiotica; the fate of foreign compounds in biological systems • Vol. 54, Issue 10 • 2024
PMID: 39387185DOI: 10.1080/00498254.2024.2415103

Discovery of GDC-0077 (Inavolisib), a Highly Selective Inhibitor and Degrader of Mutant PI3Kα.

Journal of medicinal chemistry • Vol. 65, Issue 24 • 2022
PMID: 36455032DOI: 10.1021/acs.jmedchem.2c01422

Importance of SH groups in catalysis by bovine brain acid phosphatase.

Biochimica et biophysica acta • Vol. 438, Issue 1 • 1976
PMID: 7316DOI: 10.1016/0005-2744(76)90231-x

[Comparison of the endocrine response under 2 kinds of anesthesia: neuroleptanalgesia of the chlorprothixene-dextromoramide type and venous anesthesia of the type alfadione-fentanyl].

Annales de l'anesthesiologie francaise • Vol. 16, Issue 9 • 1975
PMID: 5035

Documentation